Alzheimers

A Canadian study shows that the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer’s, the more likely they are to have amyloid plaques, the cause of the cognitive decline associated with the disease, in their brain.

An alteration in Andrés Martín’s DNA called the Jalisco mutation dramatically raises his risk for early-onset Alzheimer’s. He found a powerful ally in USC neurologist and Alzheimer’s researcher John Ringman.

USC research sheds new light on how a breakdown in the brain’s vascular system predates the accumulation of toxic plaques and tangles in the brain that bring about Alzheimer’s disease. The research suggests an earlier target for preventing dementia and Alzheimer’s.

An enzyme found in brain cells can break apart the precursors to plaques that accumulate in the organ and cause toxicity in Alzheimer’s disease, according to a new study led by Weill Cornell Medicine scientists.

University of Florida neuroscientists have validated a potential pathway to halt the progression of Alzheimer’s disease.

Findings by a team of Boston University researchers offer a new understanding of the biology of Alzheimer’s disease and may eventually offer new targets for drug treatments.

A USC event targeting African-American seniors looks more like a TV show than an academic lecture. Experts are using text messages, too, to help teach about Alzheimer's disease.

White women whose genetic makeup puts them at higher risk for Alzheimer’s disease are more likely than white men to develop the disease during a critical 10-year span in their lives, new study shows.

Now a third-year PhD student in the USC Neuroscience Graduate Program, Kwok "Chris" Im studies Alzheimer’s and immunotherapeutics, which use the immune system to fight disease.